2023-05-10 17:35:58 ET
- Heron Therapeutics ( NASDAQ: HRTX ) is scheduled to announce Q1 earnings results on Thursday, May 11th, after market close.
- The consensus EPS Estimate is -$0.20 and the consensus Revenue Estimate is $29.69M (+26.6% Y/Y).
- Over the last 1 year, HRTX has beaten EPS estimates 50% of the time and has beaten revenue estimates 0% of the time.
- Over the last 3 months, EPS estimates have seen 2 upward revisions and 0 downward. Revenue estimates have seen 0 upward revisions and 1 downward.
For further details see:
Heron Therapeutics Q1 2023 Earnings Preview